Transparency in reporting of phase 3 cancer clinical trial results

Roshal R. Patel; Vivek Verma; Clifton D. Fuller; Zachary R. McCaw; Ethan B. Ludmir

doi:10.1080/0284186X.2020.1856410

Transparency in reporting of phase 3 cancer clinical trial results

Roshal R. Patel, Vivek Verma, Clifton D. Fuller, Zachary R. McCaw, Ethan B. Ludmir

Research output: Contribution to journal › Letter › peer-review

Original language	English (US)
Pages (from-to)	191-194
Number of pages	4
Journal	Acta Oncologica
Volume	60
Issue number	2
DOIs	https://doi.org/10.1080/0284186X.2020.1856410
State	Published - 2021

ASJC Scopus subject areas

Hematology
Oncology
Radiology Nuclear Medicine and imaging

Access to Document

10.1080/0284186X.2020.1856410

Cite this

@article{304791879e3d4d8a8ec43c6085502d02,

title = "Transparency in reporting of phase 3 cancer clinical trial results",

author = "Patel, {Roshal R.} and Vivek Verma and Fuller, {Clifton D.} and McCaw, {Zachary R.} and Ludmir, {Ethan B.}",

note = "Funding Information: Outside of the submitted work, Dr. Fuller received funding and salary support from the National Institutes of Health (NIH), including: the National Institute for Dental and Craniofacial Research Establishing Outcome Measures Award (1R01DE025248/R56DE025248) and an Academic Industrial Partnership Grant (R01DE028290); NCI Early Phase Clinical Trials in Imaging and Image-Guided Interventions Program (1R01CA218148); an NIH/NCI Cancer Center Support Grant (CCSG) Pilot Research Program Award from the UT MD Anderson CCSG Radiation Oncology and Cancer Imaging Program (P30CA016672) and an NIH/NCI Head and Neck Specialized Programs of Research Excellence (SPORE) Developmental Research Program Award (P50 CA097007). Dr. Fuller received funding and salary support unrelated to this project from: National Science Foundation (NSF), Division of Mathematical Sciences, Joint NIH/NSF Initiative on Quantitative Approaches to Biomedical Big Data (QuBBD) Grant (NSF 1557679); NSF Division of Civil, Mechanical, and Manufacturing Innovation (CMMI) standard grant (NSF 1933369) a National Institute of Biomedical Imaging and Bioengineering (NIBIB) Research Education Programs for Residents and Clinical Fellows Grant (R25EB025787-01); the NIH Big Data to Knowledge (BD2K) Program of the National Cancer Institute (NCI) Early Stage Development of Technologies in Biomedical Computing, Informatics, and Big Data Science Award (1R01CA214825). Dr. Fuller received direct infrastructure support provided by the multidisciplinary Stiefel Oropharyngeal Research Fund of the University of Texas MD Anderson Cancer Center Charles and Daneen Stiefel Center for Head and Neck Cancer and the Cancer Center Support Grant (P30CA016672) and the MD Anderson Program in Image-guided Cancer Therapy. Dr. Fuller has received direct industry grant support, honoraria, and travel funding from Elekta AB. Funding Information: This study was supported by NIH grant P30 CA016672.",

year = "2021",

doi = "10.1080/0284186X.2020.1856410",

language = "English (US)",

volume = "60",

pages = "191--194",

journal = "Acta Oncologica",

issn = "0284-186X",

publisher = "Informa Healthcare",

number = "2",

}

TY - JOUR

T1 - Transparency in reporting of phase 3 cancer clinical trial results

AU - Patel, Roshal R.

AU - Verma, Vivek

AU - Fuller, Clifton D.

AU - McCaw, Zachary R.

AU - Ludmir, Ethan B.

N1 - Funding Information: Outside of the submitted work, Dr. Fuller received funding and salary support from the National Institutes of Health (NIH), including: the National Institute for Dental and Craniofacial Research Establishing Outcome Measures Award (1R01DE025248/R56DE025248) and an Academic Industrial Partnership Grant (R01DE028290); NCI Early Phase Clinical Trials in Imaging and Image-Guided Interventions Program (1R01CA218148); an NIH/NCI Cancer Center Support Grant (CCSG) Pilot Research Program Award from the UT MD Anderson CCSG Radiation Oncology and Cancer Imaging Program (P30CA016672) and an NIH/NCI Head and Neck Specialized Programs of Research Excellence (SPORE) Developmental Research Program Award (P50 CA097007). Dr. Fuller received funding and salary support unrelated to this project from: National Science Foundation (NSF), Division of Mathematical Sciences, Joint NIH/NSF Initiative on Quantitative Approaches to Biomedical Big Data (QuBBD) Grant (NSF 1557679); NSF Division of Civil, Mechanical, and Manufacturing Innovation (CMMI) standard grant (NSF 1933369) a National Institute of Biomedical Imaging and Bioengineering (NIBIB) Research Education Programs for Residents and Clinical Fellows Grant (R25EB025787-01); the NIH Big Data to Knowledge (BD2K) Program of the National Cancer Institute (NCI) Early Stage Development of Technologies in Biomedical Computing, Informatics, and Big Data Science Award (1R01CA214825). Dr. Fuller received direct infrastructure support provided by the multidisciplinary Stiefel Oropharyngeal Research Fund of the University of Texas MD Anderson Cancer Center Charles and Daneen Stiefel Center for Head and Neck Cancer and the Cancer Center Support Grant (P30CA016672) and the MD Anderson Program in Image-guided Cancer Therapy. Dr. Fuller has received direct industry grant support, honoraria, and travel funding from Elekta AB. Funding Information: This study was supported by NIH grant P30 CA016672.

PY - 2021

Y1 - 2021

UR - http://www.scopus.com/inward/record.url?scp=85101444746&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85101444746&partnerID=8YFLogxK

U2 - 10.1080/0284186X.2020.1856410

DO - 10.1080/0284186X.2020.1856410

M3 - Letter

C2 - 33307924

AN - SCOPUS:85101444746

SN - 0284-186X

VL - 60

SP - 191

EP - 194

JO - Acta Oncologica

JF - Acta Oncologica

IS - 2

ER -

Transparency in reporting of phase 3 cancer clinical trial results

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this